1. Home
  2. INCY vs ONON Comparison

INCY vs ONON Comparison

Compare INCY & ONON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Incyte Corp.

INCY

Incyte Corp.

HOLD

Current Price

$96.36

Market Cap

17.0B

Sector

Health Care

ML Signal

HOLD

Logo On Holding AG

ONON

On Holding AG

HOLD

Current Price

$34.51

Market Cap

12.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
INCY
ONON
Founded
1991
2010
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Shoe Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
17.0B
12.0B
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
INCY
ONON
Price
$96.36
$34.51
Analyst Decision
Buy
Strong Buy
Analyst Count
21
20
Target Price
$103.52
$60.15
AVG Volume (30 Days)
1.3M
5.2M
Earning Date
04-28-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
4173.33
N/A
EPS
1.47
N/A
Revenue
$3,394,635,000.00
N/A
Revenue This Year
$10.44
$19.58
Revenue Next Year
$10.99
$19.98
P/E Ratio
$65.22
$56.05
Revenue Growth
13.67
N/A
52 Week Low
$57.77
$31.41
52 Week High
$112.29
$61.29

Technical Indicators

Market Signals
Indicator
INCY
ONON
Relative Strength Index (RSI) 52.19 41.22
Support Level $93.54 $34.38
Resistance Level $108.79 $44.10
Average True Range (ATR) 3.13 1.21
MACD 0.10 0.15
Stochastic Oscillator 40.54 5.90

Price Performance

Historical Comparison
INCY
ONON

About INCY Incyte Corp.

Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes a broad array of oncology and dermatology programs.

About ONON On Holding AG

Founded in Switzerland in 2010, sportswear firm On Holding generates 93% of its sales from athletic shoes. The brand is best known for its running shoes and its distinctive CloudTec soles. On also produces athletic apparel (6% of sales) and accessories (1%). The firm's merchandise is available in more than 80 countries and is sold through both wholesale (58% of sales) and company-owned channels (42%). In 2025, On generated 58% of its sales in North America, 25% in Europe, the Middle East, and Africa, and 17% in the Asia-Pacific region.

Share on Social Networks: